retatrutide dosing clinical trial retatrutide dose Dosage: What Evidence Currently Shows – Bolt Pharmacy Retatrutide Dosing: Weekly Injections, Clinical

Lower GLP-1 equals increased appetite and weight gain

GIP receptor agonists work by targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) , stimulating additional insulin release while also influencing fat metabolism

Endogenous GLP-1 has short-lived effects, but pharmaceutical GLP-1 RAs are engineered to have far longer half-lives and therefore sustained physiological impact

9-12 weeks : If you can tolerate 2 mg once weekly, your dose will be increased to 4 mg once weekly for the next 4 weeks

The main findings so far are dose-dependent weight loss in phase 2 studies, frequent gastrointestinal side effects, and ongoing questions about long-term safety, eligibility, and approval